Ivy Brain Tumor Center Announces Initial Results of Pamiparib in Newly-Diagnosed and Recurrent Glioblastoma at the European Society for Medical Oncology (ESMO) 2022 Congress
Presented today at the ESMO Congress, Dr. Nader Sanai announced initial results in our Phase 0 clinical trial evaluating pamiparib in patients with #glioblastoma (NCT04614909). The interim analysis demonstrated that pamiparib is well-tolerated in glioblastoma patients.
Ivy Brain Tumor Center Implements New Liquid Biopsy Program to Provide Glioblastoma Patients More Personalized Care
The Ivy Brain Tumor Center announced its initiation of a ‘Liquid Biopsy’ program to obtain real-time insights into how a patient’s brain tumor is responding to experimental treatment.
In this Neurosurgery Blog Tumor Series, Dr. Nader Sanai, director of the Ivy Brain Tumor Center, discusses the unique challenges for brain tumor drug development and how the Ivy Center's Phase 0 clinical trials are creating a new paradigm.
Dr. Nader Sanai spoke with local news station, ABC15 about new developments in brain cancer research and treatment on the fourth anniversary of Senator John McCain's death.
Dr. Kelly Braun from the Ivy Brain Tumor Center at Barrow Neurological Institute spoke with Good Morning Arizona reporter Tess Rafols, about new developments and treatments for brain cancer.
The Ivy Center's Phase 0 clinical trials provide valuable data on experimental drugs used to treat brain cancer. Chief Operating Officer and Deputy Director of the Ivy Center, Shwetal Mehta, was featured in Clinical Trials Arena discussing how the Ivy Center is at the forefront of this innovative brain cancer research.
The Ivy Brain Tumor Center has announced the launch of a new Spanish-language website, recognizing the importance of providing clinical trial information in multiple languages to patients and caregivers in the U.S. and around the world.
Dr. Joe Tedesco is taking the country by storm as he sets out to ride his bike from coast to coast in honor of brain tumor survivor Nate Tomlin. Covered by 12 News, Dr. Tedesco's fundraiser is gaining traction and he has increased his goal to $20,000! Check out the full story!
InBusiness Phoenix Magazine's latest cover story they detail the Ivy Brain Tumor Center as one of the "top-ranked healthcare organizations that provide top-notch care, are innovative and known for research excellence.”
The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer, will evaluate evaluate AZD1390 in a Phase 0/1b clinical trial with patients diagnosed with recurrent grade IV gliomas.